News & Updates

Show Multimedia Only

Local data support continuation of RASIs in patients with T2D and advanced CKD

22 Dec 2022 by

Discontinuation of renin-angiotensin system inhibitors (RASIs) is associated with higher risks of cardiorenal complications and neutral risk of all-cause mortality in patients with type 2 diabetes (T2D) and advanced chronic kidney disease (CKD), according to researchers from the Chinese University of Hong Kong (CUHK).

22 Dec 2022

Obesity associated with adverse ITP outcomes

21 Dec 2022 by

In a study presented at ASH 2022, obesity was found to be associated with adverse outcomes in individuals with primary immune thrombocytopenia (ITP; formerly known as thrombocytopenia purpura).

21 Dec 2022

Maternal hypothyroidism linked to adverse pregnancy outcomes

20 Dec 2022

Pregnant women with high levels of thyroid stimulating hormone (TSH), which indicate hypothyroidism, are at risk of adverse pregnancy outcomes, a study has found.

20 Dec 2022

Obesity, overweight up risk of complications from radical cystectomy

20 Dec 2022

Body mass index is independently associated with the development of complications from radical cystectomy, reports a study. Compared to patients with normal BMI, those who are overweight and obese have a higher risk.

20 Dec 2022

Metformin may reduce COVID-19 severity in prediabetes, PCOS

19 Dec 2022

Among patients with prediabetes or polycystic ovary syndrome (PCOS), the use of metformin appears to be associated with lower incidence of severe COVID-19, according to a study.

19 Dec 2022

BREAKING THE WAVE: Transition to recovery │ Newsbite Section

19 Dec 2022

After the success of the previous online scientific conference entitled Riding the Wave, Procter & Gamble Health, in partnership with the Philippine Academy of Family Physicians and the Philippine Pharmacists Association, presented the next installment in the series, Breaking the Wave, held virtually from April 28 – 29, 2022.

19 Dec 2022

Gestational diabetes mellitus predisposes women to prediabetes, T2DM

19 Dec 2022

Among women with a history of gestational diabetes mellitus (GDM), the conversion to prediabetes or type 2 diabetes mellitus (T2DM) appears to be high, a recent study has found.

19 Dec 2022

Diabetes Mellitus DMT2 GLP1-RA Dulaglutide

15 Dec 2022

Coexisting diabetes ups risk of secondary malignancy, death in cancer patients

15 Dec 2022

In cancer patients, the presence of diabetes appears to aggravate the likelihood of developing a secondary malignancy or death, reports a recent Japan study.

15 Dec 2022

Beneficial effects of weight loss on MACE risk may come later for some

14 Dec 2022

In a cohort of middle-aged individuals from South Korea, the initial weight loss at 4 years appears to contribute to an increased risk of major adverse cardiovascular events (MACEs), which may be explained by residual cardiovascular burden, according to a study. However, the risk increase disappears among individuals with sustained weight loss ≥ 6 years.

14 Dec 2022

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Local data support continuation of RASIs in patients with T2D and advanced CKD

Obesity associated with adverse ITP outcomes

Maternal hypothyroidism linked to adverse pregnancy outcomes

Obesity, overweight up risk of complications from radical cystectomy

Metformin may reduce COVID-19 severity in prediabetes, PCOS

BREAKING THE WAVE: Transition to recovery │ Newsbite Section

Gestational diabetes mellitus predisposes women to prediabetes, T2DM

Diabetes Mellitus DMT2 GLP1-RA Dulaglutide

Coexisting diabetes ups risk of secondary malignancy, death in cancer patients

Beneficial effects of weight loss on MACE risk may come later for some